Treating psoriatic arthritis: how effective are TNF antagonists? - Wikidata - wikimedia - TriplyDB

Treating psoriatic arthritis: how effective are TNF antagonists?

Treating psoriatic arthritis: how effective are TNF antagonists?

http://www.wikidata.org/entity/Q33708854

about

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.

P2860

Q34896269-38AD416B-388A-4477-98DC-261E9A3867CA Q38271745-4CC836F9-CC67-49BA-92E0-7DAC077600ED Q38710469-D1DE629F-C534-4DFD-9105-183FCEEDCBE4

P2860

Treating psoriatic arthritis: how effective are TNF antagonists?

http://www.wikidata.org/entity/Q33708854

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Treating psoriatic arthritis: how effective are TNF antagonists?

@ast

Treating psoriatic arthritis: how effective are TNF antagonists?

@en

type

label

Treating psoriatic arthritis: how effective are TNF antagonists?

@ast

Treating psoriatic arthritis: how effective are TNF antagonists?

@en

prefLabel

Treating psoriatic arthritis: how effective are TNF antagonists?

@ast

Treating psoriatic arthritis: how effective are TNF antagonists?

@en

P1433

Q33708854-DFE85C03-B71D-4AF8-B011-FA7F91B37E38

P1476

Q33708854-2532869F-434B-4C00-8379-0C3FE5BF3E39

P2093

Q33708854-23BBC61B-93BF-4645-B60A-FD41A6606769

Q33708854-2CC0415D-3CC8-4C1D-8D78-B7C9A1E8B8AC

P2860

Q33708854-0C2B2BBD-9203-4A9B-97B1-81F7604BCEEA

Q33708854-1B1D3848-FE21-448B-B4DA-FF2DAE9121A7

Q33708854-1D9F8972-AF84-4E8E-A46C-74EE16E68A95

Q33708854-1E53D1D3-0C66-4FA5-B93A-8051BE314613

Q33708854-68F462B9-58F2-4052-8693-E8ACA6761686

Q33708854-6E00F185-EC92-4DDD-AC66-7AF7600683F6

Q33708854-72D3A467-B31B-4FAB-9EB2-EFE737084A81

Q33708854-934D65BE-1561-4996-82B4-CC5F75737E4E

Q33708854-BE757487-9C7C-4A66-8DEF-62B2312A7BDB

Q33708854-CFA3077A-BCDA-4045-8958-67A58F8FC3B4

P2888

Q33708854-C90BF9B7-31F0-46D9-9EB3-4FC798B828BC

P304

Q33708854-5C7858C0-F3CA-4440-8AB3-AA5BABD1BB63

P31

Q33708854-8AF8697E-A8BC-4B07-AF20-10929C5B5A1F

Q33708854-FB682ADB-28E3-4B4E-AE31-EC41D9BE68D5

P356

Q33708854-6E1590CC-5EDA-4DCE-9763-EA78D2D1BA86

P478

Q33708854-320B0630-DB72-4FCA-ADA0-BFEB6BA1DEB6

P577

Q33708854-70A610DF-B0C7-4368-807D-19AA48080E19

P5875

Q33708854-2C1DEB40-2834-4F6C-902A-5AF49ED1F4DB

P6179

Q33708854-5F9C0F44-02BF-4C7A-84C4-FB7AD23FAE01

P698

Q33708854-061EE833-7E55-49CC-9612-8206447233A9

P921

Q33708854-42EAF591-C938-4DB8-B3A8-70B5AA1E80F4

Q33708854-471A7859-6BB1-4B17-AD92-EB3EEF09B4D2

Q33708854-5050E16D-1527-47A2-B26B-94608F869974

Q33708854-C3BDF24D-D574-4BC2-AB58-8B724AF31184

Q33708854-D6B8FBFA-F58D-447B-B72C-9DC9A4594881

Q33708854-D828F60B-2933-4032-AA7B-E3F63D9D3C29

P932

Q33708854-E7C18895-CD89-4DAB-91F4-4489F16AE109

P356

P1433

Arthritis Research and Therapy

P1476

Treating psoriatic arthritis: how effective are TNF antagonists?

@en

P2093

Alice B Gottlieb

http://www.w3.org/2001/XMLSchema#string

Christian E Antoni

http://www.w3.org/2001/XMLSchema#string

P2860

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Current consensus and update on psoriasis therapy: a perspective from the U.S.

Psoriasis vulgaris--a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis.

The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model.

Psoriatic arthritis. Genetics and HLA antigens.

The immunologic basis for the treatment of psoriasis with new biologic agents.

Immunomodulating drugs in the management of psoriatic arthritis.

Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis.

A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis.

P2888

P304

S31-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR1016

http://www.w3.org/2001/XMLSchema#string

P478

6 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8479157

http://www.w3.org/2001/XMLSchema#string

P6179

1042759442

http://www.w3.org/2001/XMLSchema#string

P698

15228619

http://www.w3.org/2001/XMLSchema#string

P921

Tumor necrosis factor

cell surface receptor

membrane proteins

P932

2833458

http://www.w3.org/2001/XMLSchema#string